Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
about
Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community correctionsThe Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level AnalysisAccess to Addiction Pharmacotherapy in Private Health Plans.Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.Improving Coordination of Addiction Health Services Organizations with Mental Health and Public Health Services.Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care ReformThe Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal StudyUse of evidence-based treatments in substance abuse treatment programs serving American Indian and Alaska Native communities.Lessons From Medicaid's Divergent Paths On Mental Health And Addiction Services.The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.Capsule Commentary on D'Onofrio et al., Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change.Linking Individuals with Substance Use Disorders (SUDs) in Primary Care to SUD Treatment: the Recovery Management Checkups-Primary Care (RMC-PC) Pilot Study.
P2860
Q35007640-DFBC6998-3242-4C74-B8D8-C5A73FC9F1D1Q35828982-66E9809E-0745-455E-AED0-D7897A9F41B5Q36025907-5A94E677-2041-4DF8-A893-387C5931520AQ36240322-0F6319C7-D3BB-481A-B9D4-52245C91D310Q36373003-50DC244D-EB72-4BCA-89C1-28A826FD966FQ36446470-53341178-1F3A-459E-9BAE-C774E7EE8E27Q36494890-B10B8E0B-F13C-41C3-A843-0856C4E43A88Q36757250-90F341C9-42CB-4A87-982F-842AFB378B3CQ36798074-6474547D-FD71-4935-AE84-D7835077EB8FQ37729027-944A8A04-C26B-490B-B908-382B673B6621Q40315585-895D16B7-BBB3-4B9F-9402-A6B1D9E21FA8Q44349044-8E71BF0F-536E-45E7-84D9-8BB22587673DQ49579899-FA7EDC31-50A4-44C5-AC67-A2075656734F
P2860
Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Disparities in access to physi ...... programs in the United States.
@ast
Disparities in access to physi ...... programs in the United States.
@en
type
label
Disparities in access to physi ...... programs in the United States.
@ast
Disparities in access to physi ...... programs in the United States.
@en
prefLabel
Disparities in access to physi ...... programs in the United States.
@ast
Disparities in access to physi ...... programs in the United States.
@en
P2093
P2860
P356
P1476
Disparities in access to physi ...... programs in the United States
@en
P2093
Amanda J Abraham
Hannah K Knudsen
Paul M Roman
Traci Rieckmann
P2860
P304
P356
10.15288/JSAD.2013.74.258
P407
P577
2013-03-01T00:00:00Z